Hemangi Yagnik

Hemangi Yagnik has a diverse work experience in the field of regulatory operations and submission management. Hemangi is currently working as an Associate Director of Regulatory Operations at Aura Biosciences, starting in February 2023. Prior to this, they worked at REVOLUTION Medicines as a Senior Manager of Regulatory Operations from July 2022 to May 2023. Hemangi also served as a Senior Manager of Regulatory Operations and Submission Management at Ziopharm Oncology from July 2019 to July 2022.

Before joining Ziopharm Oncology, Hemangi worked at ImmunoGen, Inc. as a Regulatory Operations Specialist from January 2017 to July 2019. Prior to that, they held the same role at Puma Biotechnology, Inc. from September 2015 to December 2016. Hemangi also gained experience as a Regulatory Affairs Associate at Millennium-Takeda Pharmaceuticals from April 2014 to September 2015.

Hemangi started their career as a Regulatory Affairs Assistant at Baroque Pharmaceutical Pvt. Ltd. in July 2012 and worked there until July 2013. Hemangi had previously interned in the Production and Quality Assurance Department of the same company from May 2011 to July 2011. Overall, Hemangi Yagnik has a strong background in regulatory affairs and operations management, with progressively increasing levels of responsibility throughout their career.

Hemangi Yagnik pursued their education with a Bachelor of Science degree in Pharmacy from Gujarat Technological University, from 2008 to 2012. Later, they completed a Master of Science degree in Drug Regulatory Affairs from Northeastern University between 2013 and 2015.